Skip to content
Back to CGTX

Cognition Therapeutics Inc

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
3
Purchases
3
Sales
0
Purchase value
$32.49K
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

John Brendan DoyleChief Financial Officer
4
Filed Apr 20, 2026Period of report Apr 16, 20260001104659-26-045511
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseApr 16, 2026
Common Stock10,000$1.13$11.30K627,509Direct
Open on SEC EDGAR
Lisa RicciardiDirector · CEO & President
4
Filed Apr 20, 2026Period of report Apr 16, 20260001104659-26-045502
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseApr 16, 2026
Common Stock9,175$1.10$10.09K1,715,851Direct
Open on SEC EDGAR
Anthony CaggianoChief Medical Officer
4
Filed Apr 20, 2026Period of report Apr 16, 20260001104659-26-045499
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseApr 16, 2026
Common Stock10,000$1.11$11.10K874,906Direct
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.